Corrigendum to “Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology” [J. Cardiol. 72 (2) (2018) 113–119] (Journal of Cardiology (2018) 72(2) (113–119), (S0914508718300546) (10.1016/j.jjcc.2018.01.017))

D. Fukamachi, A. Hirayama, K. Miyauchi, S. Yasuda, H. Ogawa, H. Ito, H. Daida

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the figure regarding the answer spectrum to “What anti-thrombotic therapy do you prefer to use in AF patients 1-year after stent implantation?” had a wrong value within a column. In this Fig. 4 the yellow section (aspirin + OAC) at the column of 2016 actually corresponded to 45% rather than 49%. Although this was due to simple calculation error, we would like to humbly apologize for any convenience caused in readers of this journal.

Original languageEnglish
Number of pages1
JournalJournal of cardiology
Volume72
Issue number5
DOIs
Publication statusPublished - Nov 2018
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Corrigendum to “Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology” [J. Cardiol. 72 (2) (2018) 113–119] (Journal of Cardiology (2018) 72(2) (113–119), (S0914508718300546) (10.1016/j.jjcc.2018.01.017))'. Together they form a unique fingerprint.

Cite this